Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Interleukin 34 (IL34) ELISA Kit-Sandwich

Name: Bovine Interleukin 34 (IL34) ELISA Kit-Sandwich
SKU: EK10F226
Rating: 5 (1 reviews)

Cat. No.EK10F226

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Bovine IL34 ELISA Kit-Sandwich is designed for the quantitative determination of Bovine interleukin 34 (IL34) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Bovine IL34.

Target Species Bovine

Species Reactivity Bovine

Detection Range 62.5-4000 pg/mL

Sensitivity 12.5 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Interleukin 34 is encoded by the LOXL2 gene in cattle. Studies have demonstrated that IL-34 is released by some cell types and is involved in the differentiation and survival of macrophages, monocytes, and dendritic cells (DCs) in response to inflammation, in the development of microglia and Langerhans cells.

Target/Biomarker Bovine IL34

Target Synonym interleukin 34; C18H16ORF77; IL-34; interleukin-34

Gene ID 532685

UniProt ID A6QL48

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Bézie, S. et al. IL-34 actions on FOXP3⁺ Tregs and CD14⁺ monocytes control human graft rejection. Frontiers in immunology. 2020, 11: 1496.